JoVE Journal
Cancer Research
Cancer Research
Se requiere una suscripción a JoVE para ver este contenido.
Capítulos
Resumen
Therapy resistance often develops in patients with advanced prostate cancer, and in some cases, cancer progresses to a lethal subtype called neuroendocrine prostate cancer. Assessing the small non-coding RNA-mediated molecular changes that facilitate this transition would allow better disease stratification and identification of causal mechanisms that lead to development of neuroendocrine prostate cancer.